Fig. 7.
Fig. 7. Graphs showing the effect of ibandronate treatment (4 μg per mouse per day) on (A) hindlimb paralysis and (B) survival in 5TGM1 myeloma-bearing mice. Significant differences were not observed between myeloma-bearing mice treated with PBS or with ibandronate.

Graphs showing the effect of ibandronate treatment (4 μg per mouse per day) on (A) hindlimb paralysis and (B) survival in 5TGM1 myeloma-bearing mice. Significant differences were not observed between myeloma-bearing mice treated with PBS or with ibandronate.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal